Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An Arm-to-Disarm Strategy to Overcome Phenotypic AMR in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.23.533925Source: DataRank Database

An Arm-to-Disarm Strategy to Overcome Phenotypic AMR in Mycobacterium tuberculosis is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (27)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Shalini Birua ORCID,Sharath Chandra Mallojjala ORCID,P. Mukherjee ORCID,Samsher Singh ORCID,Grace Kaul ORCID

Live enrichment

PubMed:38260651 OpenAlex:https://openalex.org/W4360602081

National Institutes of Health

Grant: 5R35GM147183-02

Mechanistic Investigation into Modern Catalytic Reactions

NIGMS NIH HHS

Grant: R35 GM147183

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/03/23/2023.03.23.533925.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.03.23.533925

repositoryhttp://dx.doi.org/10.1101/2023.03.23.533925

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38260651

Fields of Study

Antibiotic Resistance in BacteriaCancer therapeutics and mechanismsTuberculosis Research and Epidemiology0301 basic medicine03 medical and health sciences

Keywords

ProdrugMycobacterium tuberculosisMoxifloxacinPharmacologyIntracellularDrugDrug resistanceMicrobiologyTuberculosisChemistryBiologyAntibioticsMedicineBiochemistryArticleAntimicrobial resistancedrug accumulationfluoroquinolonemycobacteriapermeabilitypersistersphenotypic antimicrobial resistance

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being